Extracorporeal treatment for refractory hyperlipidemia.

Area of Science:

• Cardiology
• Biomedical Engineering
• Lipidology

Background:

• Hyperlipidemia management often relies on conventional therapies.
• Severe or intolerant cases may necessitate advanced, non-pharmacological interventions.
• Extracorporeal techniques offer alternative treatment modalities for specific hyperlipidemia patients.

Purpose of the Study:

• To evaluate the efficacy of various extracorporeal treatments for hyperlipidemia.
• To assess the impact of selective lipid-lowering procedures on atherosclerotic plaque progression.
• To determine the role of non-pharmacological methods in managing severe hyperlipidemia.

Main Methods:

• Review of seven available extracorporeal procedures: plasma exchange, double filtration, immunoadsorption, dextran sulfate chemo-adsorption, heparin-induced LDL precipitation, lipoprotein(a) apheresis, and LDL hemoperfusion (DALI).
• Large-scale regression studies focused on five highly selective treatment modalities.
• Coronary angiograms were used for follow-up assessments after approximately two years of treatment.

Main Results:

• Extracorporeal techniques are generally indicated for severe familial hypercholesterolemia.
• Highly selective procedures demonstrated significant effectiveness in lipid reduction.
• Coronary angiograms revealed that 80% to 90% of patients experienced no plaque enlargement or even plaque reduction.

Conclusions:

• Highly selective extracorporeal treatments can effectively manage hyperlipidemia and regress atherosclerotic plaques.
• These non-pharmacological methods represent a viable therapeutic option for specific hyperlipidemia patients.
• Further research into selective apheresis techniques is warranted for cardiovascular risk reduction.